Treatment of IgG4-Related Disease With Revlimid and Rituximab

Clinical trial NCT02705638 · COMPLETED

Trial details

NCT number: NCT02705638
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Immunoglobulin G Subclass 4 Related Disease IgG4-related Disease Autoimmune Pancreatitis IgG4-related Sclerosing Cholangitis Retroperitoneal Fibrosis

Start date: 2016-04-01
Primary completion: 2019-04-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.